Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
News & Press: Breaking News

FDA Says "No Office Use" to Congress

Monday, September 15, 2014   (1 Comments)
Posted by: Dagmar Anderson
Share |

In a letter to Representatives Griffith, Green and DeGette, the Food & Drug Administration (FDA) today clearly stated it is interpreting 503A to only permit the compounding of prescriptions for individual patients. This is in direct contradiction to Congressional intent as included in several "Statements of the Record" from Senators and Congressmen that nothing in the Drug Quality & Security Act was intended to interfere with state authority over the practice of pharmacy.


Please click here to view the FDA's letter. Additional information will appear in our Capitol Connections newsletter this week.


Diane Boomsma says...
Posted Tuesday, September 16, 2014
Are there easy tools to give prescribers who want to object to this policy? thank you.

Association Management Software Powered by YourMembership  ::  Legal